
Sign up to save your podcasts
Or


There has never been a more appropriate time than today to reinvigorate and add life to our workplace. To discuss why inspiring a certain company culture as well as innovation can increase engagement and performance, I interviewed Rebecca Friese, co-founder of FLYN, leading management consultant, keynote speaker and author of "The Good Culture: The Leader's Guide to Creating a Workplace that Doesn't Suck". By identifying outdated practices from the ground floor to the boardroom, Rebecca helps a wide range of organizations from Fortune 500 behemoths to hopeful start-ups, build the capacity to implement market-leading cultural changes. At the moment, Rebecca is on a mission to help organizations not just be better, but exceptionally innovative, engaging, and forward-thinking places to work. In our informal and candid conversation, we discuss how company culture becomes visible or invisible in a typical organization, why it influences performance, how we can keep ourselves accountable with KPIs or performance metrics for performance as well as behaviors or culture, growing culture over time despite successes and failures, why engagement and innovation is so relevant to all of us today, and real world case studies of leadership approaches to implement the environment or culture with intentionality that delivers innovation.
2:51 - Highlights from Rebecca's career
6:08 - Definition of Company Culture
8:22 - Rebecca's Signature Approach to assisting organizations with Company Culture
13:30 - Designing performance metrics/KPIs that inspire accountability for behavior and stimulate the best culture
13:48 - Without aligning culture to our everyday strategy and operationalizing it through metrics or accountability there is a gap which questions the value of the culture we want to design as leaders.
16:59 - Recent case study from a Tech company with a leader of a high-performing team that was asked to leave the organization
19:42 - New trending internal metrics of managers: manager engagement indicator (MEIs) surveys
22:04 - Metrics can improve a sense of belonging of an employee when you know what part of your effort contributes to the overall success of your organization
22:35 - Rebecca's personal real world story of being mislead to be performing well without any direct feedback
25:52 - Maintaining a certain culture through company successes and setbacks
30:59 - How Rebecca's approach to helping organizations with culture has changed over the last few years
31:21 - Focus on design thinking at FLYN Consulting
32:07 - Biggest challenge is to address the unspoken needs of individuals in the workplace
33:58 - How Rebecca is linking company culture to innovation with Fortune 500 companies
34:58 - People are motivated by their ability to learn and grow
35:08 - Customers often do not know or cannot yet imagine what they really need
36:52 - Explaining what "behavior" means to a 2-year old by adding incentives, transparency, feedback, consistency, and recognition
38:26 - Innovative organizations have to unlock the basic needs of all humans for autonomy, mastery, and purpose based on Daniel Pink's book "Drive"
40:18 - How everyone can be innovative in an organization
43:11 - How Rebecca is stretching herself and lifting others currently: her mission is to help people love their workplace
In this special episode I interviewed the winners of the first ever month-long Medical Affairs Innovation Olympics competition in pharma and biotech in the fall of 2022, CEO and Co-Founder of Discreedly, Vinay Tharayil, MD, BCMAS and Co-Founder and Chief Commercial Officer, Gibu George, MD. My guests discussed why education and interactions between pharmaceutical companies and healthcare providers need to evolve and how they are extending the reach and awareness of quality, fair-balanced medical education to not only academic physicians but those in the community using their platform, Discreedly.
1:55 - Vinay Tharayil - Background. GSK Vaccines. Medical Affairs Excellence and Operations at Astellas. Passion for Medical Affairs and the MSL role. MSLs bring lots of value to the healthcare system but often go under the radar.
4:59 - How they came up with the app @Discreedly
5:27 - Vinay and Gibu's vision and philosophy of Medical Affairs
5:46 - What makes Medical Affairs critical today in influencing health care?
6:43 - Main driver for Medical Affairs is education, scientific exchange and communication
8:53 - We want to bring medical education to the community of physicians, not just academic hospitals. Discreedly aims to increase the reach of Medical Affairs to a wider audience, including the community level physicians whom we typically do not target or educate.
11:57 - What is the relevance of a pharma company communicating more information to ensure access to care and health equity today?
13:33 - We can follow patients in EPIC via electronic health records, to be able to provide pricing information immediately.
14:14 - Putting the Provider in the Captain's Chair to be able to govern the direction of the frequency of the communications they prefer with Pharma, to allow access to quality medical information in a centralized platform.
15:12 - Physicians can search product information including formulary coverage, tier level on the health plan all at their fingertips.
15:30 - We are also exploring making social determinants of health related data available to them as well.
16:06 - Why did you call the platform "Discreedly"?
18:15 - How would pharma companies use the Discreedly App?
18:24 - Back-end channel for Pharma in this platform. Med Affairs companies will be uploading content, products, disease state related information, formulary, media that may be generated. MSLs may also be available on demand, virtually, ready to engage and educated HCPs. Providers can schedule meetings with Field MA or Medical Information. The program enables real time live chatting with HCPs, live updates / notifications.
21:39 - How do the users ensure alignment with their compliance and regulatory policies to guide what information may be shared on this platform?
22:19 - What part of the Discreedly program makes it more appropriate for the community level physicians?
23:29 - We secured a partnership with Doximity and use their SSO. They do not have to create a new account if they are already registered with Doximity.
25:30 - Extensive research of preferred formats of medical education shows high variability - the way many community oncologists learn about new treatments is a private WhatsApp group
27:02 - How does your program improve quality of healthcare at the clinical point of care?
27:17 - Integration of Electronic Medical Records (EMR)/EHR data
29:47 - Can the patient's health data be submitted by their provider or hospital?
33:26 - Message to those interested in Medical Affairs or this platform
36:13 - How are you stretching yourselves and lifting others in your next project?
36:36 - Key Lessons from Vinay and Gibu: "Be bold. The only way you will find the answer is by asking the question and taking that first step. By being bold you find out that you are capable of a lot more than you think. Be ready to adapt."
This is an episode recorded a few months ago after my guest, Johan Lauritsen, CEO & Founder of PROBE, had won the Evidence Generation category in the first-ever Medical Affairs Innovation Olympics hosted by Amedea Pharma. Johan is a medical student with prior gene editing experience, entrepreneur, keynote speaker, as well as a chronic Spinal Muscular Dystrophy type 2 patient. He is dedicating himself to facilitating and accelerating appropriate and timely patient access to clinical trials by developing a new program that researches and lists all the clinical trials across the globe for which a patient who is subscribed to his program is eligible based on health records submitted, and even directly connects the patients to the research investigator of the given study. Johan's passion and professionalism are both incredible gifts we can admire as he is in the progress of publishing the company's first prototype which is aimed at accelerating innovation in healthcare and democratizing patient participation, screening, and management of their own health. Lauritsen speaks about his personal journey as a chronic patient, and his modern perspectives on adding knowledge, transparency and technology to make clinical trials more accessible to all patients and relevant to them. Enjoy this candid conversation which showcases a new solution to improve health equity, health literacy, and patient engagement in research. You will hear Johan's tremendous accomplishments and calls to action for patients, their relatives and healthy volunteers to sign up for clinical trials and participate. 1:38 Can you share your unique background with the audience? 1:53 Johan was born with Spinal Muscular Dystrophy Type 2 (5qsma2) 5:59 For those not in healthcare, can you describe CRISPR gene editing? 8:03 Can you describe some of the processes people to know about and how clinical trials have changed. 13:25 Q: Is there routine prenatal screening or testing for SMA? In late 2022, all hospitals in Denmark implemented pre-natal screening for SMA. Johan fell when he was 3 and could no longer get back up. 14:33 SMA patients have won the Olympics before as well as the first ever Medical Affairs Innovation Olympics in the case of Johan 17:23 How has the data exchange in clinical trials accelerated and improved lately to ensure patients know about their results as soon as possible? 18:24 Clinical trials represent the most expensive, time consuming, and critical part of drug development. Patient recruitment continues to be a challenge because inclusion criteria are often determined from the investigators' perspectives rather than those of patients. Patients' inclusion criteria have now become more loose, allowing us to include more patients. 21:20 "Pharma companies do not have a realistic grasp of the real world patient population in a disease state for which they are developing treatments. Thus their study inclusion criteria are often inaccurate or irrelevant." 21:33 Only 15% of the minority populations are represented in clinical trials according to latest research. 22:10 Q: What is your company PROBE doing to improve access to clinical study for patients worldwide? 24:33 PROBE - While establishing a community of people that wants to participate in clinical trials, we are developing a tool that makes them accessible to them. We are also addressing health literacy as many patients want to be in a trial but they do not know where to find it or how to interpret the inclusion criteria or their own condition. 26:36 What kind of tool or app has PROBE created for clinical trial patients? 27:30 The App shows patients a list of clinical trials for which they are eligible. It connects the patients with the researchers, and therefore is a win-win for both researchers and patients. 29:47 Can the patient's health data be submitted by their provider or hospital? 31:34 Who are the members of the PROBE team? 34:13 Expecting to release its app at the end of January 2023.
This is part 2 of a memorable conversation I recently had with Peter High, President at Metis Strategy, a premier advisory firm in business strategy, data transformation, international growth, mergers & acquisitions. Peter is the host of the first, longest-running technology podcast called "Technovation", keynote speaker, regular Forbes columnist, and author of the book "Getting to Nimble". The audio podcast is available across all platforms. In this part of the discussion, Peter candidly shares his lessons redefining productivity, performance metrics, and the legacy of information technology and modern enterprise executives in general. Enjoy the show - here are the highlights below!
PEOPLE AND PRODUCTIVITY Q: Recent studies have published how many different employers began to use data to monitor their employees (“the worker productivity score”) which backfired because they were more likely to break rules. Q9: How do you interpret such results and what recommendations do you have in applying the new technology now available and analyzing data appropriately to guide decisions that impact our employees? LEGACY AND RESPONSIBILITY Q: What is your personal opinion and recommendation to CIOs and Tech leaders about the need to integrate and incentivize Corporate Social Responsibility, Type B Corporations and Responsible AI training and policies into their businesses? DATA MATURITY Q: What are the different stages of becoming a digitally mature company? Q: What makes the DevOps specialty in technology companies an important case study to learn from for other industries such as pharma and companies? METRICS Q: How do we design the types of contests and metrics that matter in a competitive environment whether or not we generate revenue directly? Are there particular trends you have seen in various organizations or industries in some of the most effective performance metrics? LEGACY Andy Warhol once said: “The idea is not to live forever but to leave ideas that will.” Q: As you look ahead into the future of some of your favorite innovative companies, what are some specific examples or the elements of a potential legacy and timeless values that businesses in the Tech industry will leave for future generations to come? Peter High: "It's the ideas they leave behind that leave a legacy and philosophy. It's the family tree we leave behind. How many reports of ours go on to lead other organizations?"
1:55 - Q1: How did this popular #NephJC journal club start? 5:46 - Journal Club based on "Flipping the Classroom" concept 6:59 - Journal Club audience is mainly physicians aged 40+ 8:20 - Structure of the NephJC Journal Club is supported by multi-channel learning with re-informcement (1. Blog Summary, 2. Visual Abstract, 3. Tweetorial, 4. Podcast, 5. Weekly Newsletter) 10:11 - Q2: How do the busy physicians find time to attend a new format of education online and find it valuable? 11:07 - Modern Form of Medical Education - Conversational Tone 13:03 - Q3: How has the use of social media changed during the pandemic over among physicians? 14:09 - Pandemic Case Study: NephJC created critical new resources for nephrologists to address concerns or rumor about ACE-inhibitors and their effect on COVID 16:00 - Started to build evidence review teams on the fly to analyze treatment guidelines, ACE evidence, etc. They built isolated webpages - COVID in dialysis, COVID in transplant, in hypertension, etc. We created an incredible resource for the community at a time when they had lots of questions. 17:02 - Pandemic resources increased NephJC website visits 10x 17:45 - Q4: Can you contrast Twitter vs other social media platforms and share success factors of building a community there? 22:40 - Q5: Was there a turning point when the #NephJC exploded? 23:16 - #NephJC started a global internship program. Interns from 35 different countries participate and are trained on writing blog articles, Tweet chats / tweetorials, virtual abstracts, podcasts. They then started many projects of their own. One of the spinoffs of the Curbsiders is the pediatricians' version called "Cribsiders". Website called "Nephpocus" - point of care ultrasound. 26:25 - Q6: Can you describe your system of multi channel communication and how it all works together? 28:41 - Q7: What is a Tweetorial and how does it work? 30:25 - Q8: What are some of the most effective formats to educate in your opinion? Do you use video on Twitter? 31:42 - Q9: How do you test the quality of the education via social media? Ian Lang quote "Teaching without testing is like cooking without tasting, reading without writing" 33:15 - Q10: How do you incorporate all of the different parts of your system together most efficiently? 35:14 - Q11: Are you pursuing any new channels or topics at #NEPHJC? 37:45 - Q12: How do you extend your education to patients? 38:25 - Comment: Lots of poor quality medical information online - patients beware! 39:23 - Need to Close the Knowledge Gap in Medicine that Increases over time despite Experience years gained 41:31 - Q13: Q: How do you think pharma companies can educate patients and physicians via social media?
From the publisher's feed